Cocrystal Pharma to Present Clinical Data on its Potent Pan-genotypic NS5B Non-nucleoside Inhibitor CC-31244 at the Asian Pacific Association for the Study of the Liver (APASL) Annual Meeting
Sign up for email alerts
Be the first to receive breaking newsSign up today
Cocrystal Pharma, Inc. is a pharmaceutical company with a mission to discover novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. Cocrystal Pharma employs unique nucleoside chemistry and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. These technologies and our market-focused approach to drug discovery are designed to efficiently deliver small molecule therapeutics that are safe, effective and convenient to administer.